These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37884171)

  • 1. The bcl6 corepressor mutation regulates the progression and transformation of myelodysplastic syndromes by repressing the autophagy flux.
    Chen JN; Jin JC; Guo J; Tao Y; Xu FH; Liu Q; Li X; Chang CK; Wu LY
    Int J Biochem Cell Biol; 2023 Dec; 165():106480. PubMed ID: 37884171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.
    Li X; Xu F; Zhang Z; Guo J; He Q; Song LX; Wu D; Zhou LY; Su JY; Xiao C; Chang CK; Wu LY
    Clin Epigenetics; 2021 Aug; 13(1):169. PubMed ID: 34461985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
    Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
    Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
    Watson AS; Mortensen M; Simon AK
    Cell Cycle; 2011 Jun; 10(11):1719-25. PubMed ID: 21512311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
    Lin TL; Nagata Y; Kao HW; Sanada M; Okuno Y; Huang CF; Liang DC; Kuo MC; Lai CL; Lee EH; Shih YS; Tanaka H; Shiraishi Y; Chiba K; Lin TH; Wu JH; Miyano S; Ogawa S; Shih LY
    Haematologica; 2014 Jan; 99(1):28-36. PubMed ID: 23996483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying the impact of polycomb complex component disruption in human cancers.
    Yamamoto Y; Abe A; Emi N
    Mol Cancer Res; 2014 Apr; 12(4):479-84. PubMed ID: 24515802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome.
    Badaat I; Mirza S; Padron E; Sallman D; Komrokji R; Song J; Hussaini MO
    J Clin Pathol; 2020 Apr; 73(4):209-212. PubMed ID: 31771970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal architecture of secondary acute myeloid leukemia.
    Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
    N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia.
    Zhang L; Wu M; Guo W; Zhu S; Li S; Lv S; Li Y; Liu L; Xing Y; Chen H; Liu M; Peng S; Chen Y; Yi Z
    Biomed Pharmacother; 2023 Oct; 166():115358. PubMed ID: 37634473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.
    Matos A; Magalhães SMM; Rauh MJ
    Adv Exp Med Biol; 2021; 1326():1-10. PubMed ID: 33385175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
    Coskun FR; Percin-Pacal F; Emrence Z; Ar MC; Abaci N; Unuvar A; Eskazan AE; Elverdi T; Salihoglu A; Seflekci Y; Karakas Z; Soysal T; Sirma-Ekmekci S
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress on genes associated with transformation of myelodysplastic syndromes to acute myeloid leukemia].
    Zhu C; Ma Y; Xu XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):873-8. PubMed ID: 24989313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
    Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
    Thol F; Weissinger EM; Krauter J; Wagner K; Damm F; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Ganser A; Heuser M
    Haematologica; 2010 Oct; 95(10):1668-74. PubMed ID: 20494930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
    Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.
    Thol F; Winschel C; Lüdeking A; Yun H; Friesen I; Damm F; Wagner K; Krauter J; Heuser M; Ganser A
    Haematologica; 2011 Dec; 96(12):1870-3. PubMed ID: 21880636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis.
    Kelly MJ; So J; Rogers AJ; Gregory G; Li J; Zethoven M; Gearhart MD; Bardwell VJ; Johnstone RW; Vervoort SJ; Kats LM
    Nat Commun; 2019 Mar; 10(1):1347. PubMed ID: 30902969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes.
    Yoshida A; Zokumasu K; Wano Y; Yamauchi T; Imamura S; Takagi K; Kishi S; Urasaki Y; Tohyama K; Ueda T
    Haematologica; 2012 Sep; 97(9):1372-9. PubMed ID: 22419576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology.
    Cho YU; Jang S; Seo EJ; Park CJ; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Koh KN; Im HJ; Seo JJ; Park SH; Park YM; Lee JK
    Leuk Lymphoma; 2015; 56(8):2301-8. PubMed ID: 25487075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.